Association between transcutaneous oxygen saturation within 24 h of admission and mortality in critically ill patients with non-traumatic subarachnoid hemorrhage: a retrospective analysis of the MIMIC-IV database

Junjie Liu,Zongxu Zhao,Jianmin Li,Qiuhua Zhang,Yichao Wang,Junwei Zhang
DOI: https://doi.org/10.3389/fneur.2023.1292260
IF: 3.4
2023-11-21
Frontiers in Neurology
Abstract:Background: In critically ill patients, transcutaneous oxygen saturation (SpO 2 ) upon admission is typically associated with in-hospital mortality. Nevertheless, the available information for patients with non-traumatic subarachnoid hemorrhage (SAH) is limited. In our study, our objective was to assess the correlation between SpO 2 levels and mortality among patients diagnosed with severe SAH. Methods: In this study, we extracted data from the Medical Information Marketplace in Intensive Care (MIMIC-IV) database, which comprises information on critically ill patients. By employing matching ICD-9 and ICD-10 codes, we identified 3,328 patients diagnosed with SAH. Every individual who was admitted to the intensive care unit (ICU) had their SpO 2 data and various covariates, including age, sex, diagnosis, and duration of stay, recorded upon admission. Subsequently, the patients were categorized into three distinct groups according to their SpO 2 levels: low (≤95%), moderate (95–98%), and high (≥98%). To investigate the association between percutaneous oxygen saturation and mortality in patients with severe SAH, logistic regression, and cubic spline models were utilized. The main outcomes of interest were 28- and 90-day mortality rates. Additionally, subgroup analyses were conducted to evaluate these correlations and assess the consistency of interactions. Results: A cohort of 864 patients diagnosed with non-traumatic SAH was included in this study. The correlation between SpO 2 and mortality displayed a U-shaped curve when utilizing a finite cubic spline function (non-linearity < 0.001), with the nadir in the probability of in-hospital death at 96%. Mortality at 28 and 90 days showed an inverse correlation with SpO 2 < 96% (adjusted odds ratio [OR], 0.8; 95% confidence interval [CI], 0.67–0.95, and 0.76; 95% CI, 0.6–0.96). Conversely, there was a positive correlation between percutaneous oxygen saturation (SpO 2 ) levels of ≥96% and mortality rates at both 28 and 90 days (adjusted OR, 1.17; 95% CI, 1.02–1.35 and 1.2; 95% CI, 1.05–1.39). Conclusion: In patients with severe subarachnoid hemorrhage, the association between SpO 2 and mortality at 28 and 90 days demonstrated a U-shaped pattern. When SpO 2 levels were between 95 and 98%, both short- and long-term mortality rates were at their lowest. Patients with significant subarachnoid hemorrhage had a lower chance of survival when their SpO 2 values were either high or low.
neurosciences,clinical neurology
What problem does this paper attempt to address?